Rare diseases
Investigational molecules
Locations
Back to Spain72 clinical trials in Vitoria, Spain across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Efficacy and Safety of ALKS 2680 and Alixorexton in Adults with Narcolepsy Type 1
SpainPhase 3 Randomized, Double‑Blind, Placebo‑Controlled Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 2
SpainPhase 3 Randomized Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 1
SpainLong-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis
SpainBI 3000202 in Patients with Moderate to Severe Systemic Lupus Erythematosus
SpainStudy on the Long-term Safety of TAK-861 for Patients with Narcolepsy Type 1
SpainStudy on Long-Term Safety of Ianalumab for Patients with Systemic Lupus Erythematosus
SpainPhase 3 study comparing linvoseltamab and daratumumab in high‑risk smoldering multiple myeloma patients
SpainRinatabart Sesutecan plus bevacizumab vs standard care as maintenance for recurrent platinum‑sensitive ovarian cancer after second‑line chemotherapy
SpainLong‑Term Safety and Efficacy of Infigratinib in Children with Hypochondroplasia
SpainStudy of belantamab mafodotin with drug combination in adults aged 18 years and older with relapsed or refractory multiple myeloma
SpainA study to evaluate the effects of zenagamtide in people with overweight or obesity and obstructive sleep apnoea not treated with positive airway pressure
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on breast cancer treatments, including studies of atezolizumab with chemotherapy and novel approaches for HER2-positive breast cancer. Additional research explores treatments for bladder cancer and pancreatic adenocarcinoma.
Researchers are evaluating both immunotherapy and targeted treatments to improve patient outcomes.
Comprehensive studies examining treatments for Sjögren's Syndrome and systemic lupus erythematosus. Research includes evaluation of novel therapies like dazodalibep and efgartigimod for managing autoimmune conditions.
Focus on long-term safety and efficacy of new therapeutic approaches.
Studies investigating treatments for multiple sclerosis, narcolepsy, and idiopathic hypersomnia. Research includes evaluation of remibrutinib and novel sleep disorder therapies.
Emphasis on developing targeted treatments for better disease control.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
